Cigna Group

NYSE: CI · Real-Time Price · USD
295.90
5.55 (1.91%)
At close: Aug 15, 2025, 12:22 PM

Cigna Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
261.22B 254.47B 244.38B 229.75B 216.01B 204.15B 195.19B 189.86B 186.02B 182.8B 180.02B 180.03B 179.19B 176.99B 174.27B 170.4B 167.03B 163.14B
Cost of Revenue
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Gross Profit
193.99B 254.47B 244.38B 229.75B 216.01B 204.15B 195.19B 189.86B 186.02B 182.8B 180.02B 180.03B 179.19B 176.99B 174.27B 170.4B 158.57B 154.68B
Operating Income
7.45B 7B 5.43B 3.45B 4.1B 3.99B 5.51B 6.65B 8.3B 8.4B 8.37B 8.58B 7.14B 7.06B 7.01B 10.85B 10.59B 10.98B
Interest Income
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Income
6.87B 6.84B 5.27B 3.45B 4.1B 3.99B 5.51B 6.65B 8.3B 8.4B 8.37B 8.35B 6.92B 6.84B 6.78B 10.85B 10.59B 10.98B
Net Income
5.02B 5.03B 3.43B 3.04B 3.71B 3.62B 5.16B 5.3B 6.65B 6.75B 6.68B 6.63B 5.49B 5.4B 5.37B 8.38B 8.15B 8.44B
Selling & General & Admin
15.1B 15.35B 14.84B 15.04B 15.24B 14.99B 14.82B 14.24B 13.61B 13.44B 13.17B 13.35B 13.29B 13.03B 13.03B 13.33B 13.54B 13.95B
Research & Development
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Expenses
177.47B 232.28B 224.27B 211.26B 196.67B 185.16B 174.85B 168.96B 164.11B 160.96B 158.48B 158.32B 158.97B 157.12B 154.46B 146.22B 142.89B 138.2B
Operating Expenses
192.57B 247.63B 239.12B 226.3B 211.91B 200.15B 189.67B 183.21B 177.72B 174.4B 171.66B 171.68B 172.27B 170.15B 167.49B 159.55B 156.44B 152.16B
Interest Expense
1.44B 1.48B 1.44B 1.43B 1.42B 1.41B 1.45B 1.41B 1.35B 1.29B 1.23B 1.2B 1.2B 1.19B 1.21B 1.25B 1.28B 1.36B
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
253.94B 247.63B 239.12B 226.3B 211.91B 200.15B 189.67B 183.21B 177.72B 174.4B 171.66B 171.68B 172.27B 170.15B 167.49B 159.55B 156.44B 152.16B
Income Tax Expense
1.47B 1.44B 1.49B 99M 123M 137M 141M 1.19B 1.51B 1.55B 1.61B 1.66B 1.37B 1.38B 1.37B 2.42B 2.41B 2.51B
Shares Outstanding (Basic)
266.18M 280.29M 277.78M 278.46M 281.13M 286.46M 294.56M 294.06M 294.51M 295.71M 305.41M 303.85M 315.12M 318.49M 329.64M 335.17M 341.48M 348.25M
Shares Outstanding (Diluted)
268.15M 283.22M 277.78M 281.4M 284.05M 286.46M 294.56M 297.13M 296.88M 299M 305.41M 307.52M 315.12M 321.28M 329.64M 337.58M 344.93M 351.98M
EPS (Basic)
18.26 18.01 12.32 10.68 12.82 12.27 17.52 17.86 22.14 22.12 21.60 21.16 16.93 16.29 15.86 23.92 22.89 23.36
EPS (Diluted)
18.14 17.88 12.24 10.60 12.71 12.18 17.39 17.73 21.96 21.93 21.42 20.97 16.80 16.16 15.73 23.80 22.78 23.26
EBITDA
10.28B 11.02B 9.48B 7.78B 8.53B 8.43B 9.99B 11.07B 12.62B 12.66B 12.53B 12.49B 11.07B 10.95B 10.91B 14.99B 14.74B 15.17B
EBIT
8.31B 8.31B 6.7B 4.88B 5.52B 5.4B 6.96B 8.06B 9.65B 9.69B 9.6B 9.55B 8.12B 8.03B 7.99B 12.1B 11.88B 12.35B
Depreciation & Amortization
1.97B 2.71B 2.77B 2.89B 3.01B 3.03B 3.04B 3B 2.96B 2.97B 2.94B 2.94B 2.95B 2.92B 2.92B 2.89B 2.86B 2.82B